Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-25-111601
Filing Date
2025-11-13
Accepted
2025-11-13 19:38:57
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 15546
  Complete submission text file 0001104659-25-111601.txt   17256
Mailing Address 5956 SHERRY LANE SUITE 1365 DALLAS TX 75225
Business Address 5956 SHERRY LANE SUITE 1365 DALLAS TX 75225 214-468-0008
Prosight Management, LP (Filed by) CIK: 0001617201 (see all company filings)

EIN.: 263706721 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A

Mailing Address BIOPOLE ROUTE DE LA CORNICHE 3B EPALINGES V8 1066
Business Address BIOPOLE ROUTE DE LA CORNICHE 3B EPALINGES V8 1066 41 21 653 02 00
ADC Therapeutics SA (Subject) CIK: 0001771910 (see all company filings)

EIN.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-91517 | Film No.: 251480482
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)